KAPOSI SARCOMA
Clinical trials for KAPOSI SARCOMA explained in plain language.
Never miss a new study
Get alerted when new KAPOSI SARCOMA trials appear
Sign up with your email to follow new studies for KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets skin cancer in HIV patients
Disease control Recruiting nowThis study is testing whether the drug ixazomib can shrink Kaposi sarcoma skin tumors. It will involve 41 adults with measurable skin lesions, including people living with HIV. Participants will take the drug orally in cycles for up to a year to see if it controls the cancer and …
Matched conditions: KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Immune-Boosting shot tested for HIV-Related cancer
Disease control Recruiting nowThis study is testing whether a lab-made protein called CYT107 can shrink Kaposi sarcoma tumors in people living with HIV. Participants receive weekly injections for four weeks to see if boosting their immune system helps fight the cancer. The goal is to see if this approach can …
Matched conditions: KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test new drug duo to fight Virus-Driven cancers
Disease control Recruiting nowThis early-stage study aims to find a safe dose of two drugs, pomalidomide and nivolumab, for adults whose cancers are caused by viruses. It is for people with cancers like Kaposi sarcoma, certain lymphomas, and HPV-linked cancers that have not responded to standard treatments. T…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Peer power: new program aims to slash cancer deaths in Zambia's youth with HIV
Disease control Recruiting nowThis study tests a new support program to help young people living with HIV in Zambia get cancer diagnosed earlier and stick with their treatment. It will train peers to offer counseling and education to overcome barriers to care. The goal is to reduce early deaths from cancers l…
Matched conditions: KAPOSI SARCOMA
Phase: NA • Sponsor: Implenomics • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test 'Tumor-Infecting' virus as new weapon against tough cancers
Disease control Recruiting nowThis is an early-stage study to find a safe dose of an experimental therapy called MQ710 for people with advanced solid tumors that have returned, spread, or stopped responding to standard treatments. The therapy is a modified virus designed to be injected directly into tumors. R…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Breast cancer pill tested against rare skin cancer
Disease control Recruiting nowThis study is testing if a drug called abemaciclib, currently used for breast cancer, can safely treat Kaposi Sarcoma (KS), a skin cancer often linked to HIV. Researchers want to find the right dose and see if it can shrink KS lesions. The trial is open to adults with KS, whether…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
NASA-Inspired 3D camera aims to revolutionize skin cancer tracking
Diagnosis Recruiting nowThis study is testing a new 3D camera system called SkinScan3D to improve how doctors monitor Kaposi sarcoma skin tumors. The device takes detailed 3D pictures to measure tumor height and volume, which may detect treatment responses earlier than standard 2D photos. Researchers wi…
Matched conditions: KAPOSI SARCOMA
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC
-
Scientists track rare cancer for a decade to unlock its secrets
Knowledge-focused Recruiting nowThis study aims to understand how Kaposi sarcoma (KS), a cancer often linked to HIV, behaves over many years. Researchers will observe 150 adults with KS, tracking their health through regular exams, scans, and tissue samples for up to 10 years. The goal is to learn why the disea…
Matched conditions: KAPOSI SARCOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC